CompoAtlas

E-Brake

E-Brake, licence 80066496: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Natural health product licensed in Canada

Licence holder
Magnum Nutraceuticals Inc.
NPN or DIN-HM
80066496
Status
Active licence
Licence date
20 January 2016
Revision date
5 January 2024
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Prunus africana

Source : Écorce (tige)

Extract : Matériel brut sec

Extraction ratio : 3:1

Dry plant equivalent : 100 milligramme

Potency : 15.0 % Phytosterols

33.33 milligrammeNot calculated
Piper nigrum

Source : Fruit

Extract : Matériel brut sec

Extraction ratio : 25:1

Dry plant equivalent : 41.75 milligramme

Potency : 95.0 % Piperine

1.67 milligrammeNot calculated
Vitamine D

Source : Cholécalciférol

Potency : 133.33 UI

3.33 microgrammesNot calculated
Brassaiopsis glomerulata

Source : Feuille et tige

Extract : Matériel brut sec

Extraction ratio : 10:1

Dry plant equivalent : 1.6667 Grammes

166.67 milligrammeNot calculated
(2S)-7-[[6-O-(6-Déoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-méthoxyphényl)-4H-1-benzopyrane-4-one

Source : Hespéridine

33.33 milligrammeNot calculated
Urtica dioica

Source : Sommité

Extract : Matériel brut sec

Extraction ratio : 4:1

Dry plant equivalent : 120 milligramme

30.0 milligrammeNot calculated

Non-medicinal ingredients

Bleu 1, Gélatine, Stéarate de magnésium, Cellulose microcristalline, Dioxyde de silicium

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19.0 Année(s)3.0 Capsule1.0 Tous les jours

Uses authorised in Canada

Source of antioxidant(s)/Provides antioxidants Helps in the development and maintenance of bones and teeth. Helps in the absorption and use of calcium and phosphorus. Calcium intake, when combined with sufficient Vitamin D, a healthy diet and regular exercise may reduce the risk of developing osteoporosis. Helps reduce the urologic symptoms (e.g. weak urine flow, incomplete voiding, frequent daytime and nighttime urination) associated with benign prostatic hyperplasia.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80066496

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2024. Photograph the packaging to check whether it has changed.

Has the product changed? Photograph the packaging.

List recorded in 2024. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line